The ERBB3 mRNA level was dramatically higher in bladder, colorectal, kidney, lung, ovarian, and prostate cancer tissues and significantly lower in the brain and CNS, esophageal, head and neck, lymphoma, myeloma, and sarcoma cancers compared with the corresponding normal tissues. The gene discussed is ERBB3; the disease is prostate cancer.